- Home
- STLD vs TEVA Comparison
STLD vs TEVA Comparison
Compare STLD & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | STLD | TEVA |
|---|---|---|
| Founded | 1993 | 1901 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Steel/Iron Ore | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.5B | 30.2B |
| IPO Year | 1996 | N/A |
Fundamental Metrics
Financial Performance| Metric | STLD | TEVA |
|---|---|---|
| Price | $165.64 | $28.38 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 8 |
| Target Price | ★ $174.00 | $27.00 |
| AVG Volume (30 Days) | 1.2M | ★ 11.4M |
| Earning Date | 01-21-2026 | 11-05-2025 |
| Dividend Yield | ★ 1.21% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 7.51 | 0.62 |
| Revenue | ★ $17,634,671,000.00 | $16,776,000,000.00 |
| Revenue This Year | $7.16 | $4.74 |
| Revenue Next Year | $9.40 | $0.48 |
| P/E Ratio | ★ $22.01 | $46.12 |
| Revenue Growth | N/A | ★ 0.02 |
| 52 Week Low | $103.17 | $12.47 |
| 52 Week High | $172.94 | $28.68 |
Technical Indicators
Market Signals| Indicator | STLD | TEVA |
|---|---|---|
| Relative Strength Index (RSI) | 59.67 | 80.93 |
| Support Level | $152.54 | $24.01 |
| Resistance Level | $172.94 | $26.96 |
| Average True Range (ATR) | 4.33 | 0.68 |
| MACD | 0.48 | 0.19 |
| Stochastic Oscillator | 62.60 | 94.65 |
Price Performance
Historical ComparisonAbout STLD Steel Dynamics Inc.
Steel Dynamics Inc operates as a domestic steel producer and metal recycler in the United States. The company's product portfolio comprises hot rolled sheet, hot rolled plate, painted sheet products, cold rolled sheet, and others. Its reportable segments are steel operations, metals recycling operations, steel fabrication operations, and aluminum operations. Maximum revenue is generated from its steel operations segment, which consists of manufacturing various steel products and numerous coating operations. Its primary sources of revenue are currently from the manufacture and sale of steel products, the processing and sale of recycled ferrous and nonferrous metals, and the fabrication and sale of steel joists and deck products.
About TEVA Teva Pharmaceutical Industries Limited
Teva Pharmaceutical, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.